✦ LIBER ✦

Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma

✍ Scribed by A. SANTILLAN; Y.W. KIM; M.L. ZAHURAK; G.J. GARDNER; R.L. GIUNTOLI II; I.M. SHIH; R.E. BRISTOW

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recurrent low-grade serous ovarian carci

✍ David M. Gershenson; Charlotte C. Sun; Diane Bodurka; Robert L. Coleman; Karen H 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 155 KB

High-grade serous carcinoma arising in a

✍ M Ruhul Quddus; Lanita B Rashid; Katrine Hansen; C James Sung; W Dwayne Lawrence 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 831 KB

Nuclear size distinguishes low- from hig

✍ Chih-Yi Hsu; Robert J. Kurman; Russell Vang; Tian-Li Wang; Jan Baak; Ie-Ming Shi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 335 KB

PAX2 expression in low malignant potenti

✍ Liu, Jinsong; Deavers, Michael T; Malpica, Anais; Wolf, Judith K; Lu, Karen H; S 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 382 KB

Clinicodemographic factors influencing o

✍ Matthew P. Schlumbrecht; Charlotte C. Sun; Karen N. Wong; Russell R. Broaddus; D 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

Genomic analysis of genetic heterogeneit

✍ Cooke, S L; Ng, C K Y; Melnyk, N; Garcia, M J; Hardcastle, T; Temple, J; Langdon 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 622 KB